A detailed history of Keb Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keb Asset Management, LLC holds 4,300 shares of BMY stock, worth $173,978. This represents 0.09% of its overall portfolio holdings.

Number of Shares
4,300
Previous 4,300 -0.0%
Holding current value
$173,978
Previous $220,000 5.91%
% of portfolio
0.09%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023

SELL
$68.48 - $81.09 $1,643 - $1,946
-24 Reduced 0.56%
4,300 $309,000
Q3 2022

Oct 27, 2022

BUY
$0.13 - $76.84 $3 - $1,844
24 Added 0.56%
4,324 $307,000
Q2 2022

Aug 09, 2022

BUY
$72.62 - $79.98 $312,266 - $343,914
4,300 New
4,300 $331,000
Q1 2022

May 09, 2022

SELL
$61.48 - $73.72 $279,856 - $335,573
-4,552 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$53.63 - $62.52 $244,123 - $284,591
4,552 New
4,552 $284,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $86B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Keb Asset Management, LLC Portfolio

Follow Keb Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keb Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keb Asset Management, LLC with notifications on news.